Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study-Reference-Cited by-同舟云学术

Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study

Published:2019-10-30 Issue:2 Volume:36 Page:217-230
ISSN:1569-5794
Container-title:The International Journal of Cardiovascular Imaging
language:en
Short-container-title:Int J Cardiovasc Imaging

Author:

Giglioli Cristina^ORCID,Formentini Chiara,Romano Salvatore Mario,Cecchi Emanuele,Baldereschi Giorgio Jacopo,Landi Daniele,Chiostri Marco,Prati Francesco,Marchionni Niccolò

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s10554-019-01719-1.pdf

Reference41 articles.

1. Sarno G, Lagerqvist B, Frobert O, Nilsson J, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S (2012) Lower risk of stent thrombosis and restenosis with unrestricted use of “new-generation” drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 33:606–613

2. Van Dyck CJ, Hoymans VY, Haine S, Vrints CJ (2013) New-generation drug-eluting stents: focus on Xience V® Everolimus-eluting stent and Resolute® Zotarolimus-Eluting Stent. J Interv Cardiol 3:278–286

3. Nakano M, Virmani R (2015) Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice. Cardiovasc Interv Ther 30:1–11

4. Ong AT, McFadden EP, Regar E, De Jaegere PP, Van Domburg RT, Serruys PW (2005) Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45:2088–2092

5. Pfisterer M, Brunner-LaRocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48:2584–2591

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology in development of next generation of stent and related medical devices: Current and future aspects;WIREs Nanomedicine and Nanobiotechnology;2024-03

2. Computational simulation of stent thrombosis induced by various degrees of stent malapposition;Frontiers in Bioengineering and Biotechnology;2022-11-14

3. Malapposed Struts with Cre8, Biomatrix, and Xience Stents Assessed with OCT Immediately after Implantation and at 6-Month Follow-Up: Can the Different Biomechanical Characteristics of the Three Stents Impact on Struts Malapposition?;Journal of Interventional Cardiology;2021-04-09

4. Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography;The International Journal of Cardiovascular Imaging;2020-05-08

5. The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile;Expert Review of Medical Devices;2020-03-18